Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey R. SträterH. VielhaberU. Nowak-Göttl THROMBOPHILIA Pages: S122 - S125
Hemothorax under thrombolytic therapy with recombinant tissue V. VarnholtH. RingeG. Gaedicke THROMBOPHILIA Pages: S140 - S142
Heparin-induced thrombocytopenia in paediatric patients – a review of the literature and a new case treated with danaparoid sodium Oliver RanzePetra RanzeAndreas Greinacher THROMBOPHILIA Pages: S130 - S133
Clinical importance of prothrombotic risk factors in pediatric patients with malignancy – impact of central venous lines R. KnöflerE. SiegertM. Kabus THROMBOPHILIA Pages: S147 - S150
Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer R. MertensH. BrostU. Nowak-Göttl THROMBOPHILIA Pages: S154 - S158
Prevalence and outcome of intracranial haemorrhage in haemophiliacs – a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH) J. KlingeK. Aubergerthe paediatric group of the German Society of Thrombosis and Haemostasis HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S162 - S165
Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: Is there a clinical relevance? F. KertzscherA. E. MüllerH. Lenk HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S177 - S179
A 2-year-old boy with recurrent severe bleeding: von Willebrand type 2B and ITP – or von Willebrand type 2B alone? R. RauchU. BuddeJ. Klinge HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S171 - S173
Can 3 oral 2 mg doses of vitamin K effectively prevent late vitamin K deficiency bleeding? R. von KriesA. HachmeisterU. Göbel VITAMIN K Pages: S183 - S186
Systemic meningococcal infection: Which children may benefit from adjuvant haemostatic therapy? Results from an observational study W. NürnbergerR. v. KriesU. Göbel CONSUMPTION COAGULOPATHY AND DIC Pages: S192 - S196
Anticoagulant response to Agkistrodon Contortrix venom (ACV) in infants and children with genetic defects in the protein C anticoagulant pathway A. KirschbaumR. JunkerU. Nowak-Göttl LABORATORY INVESTIGATIONS Pages: S203 - S204
Plasma values for u-PA in children P. ZeitlerV. Schuster LABORATORY INVESTIGATIONS Pages: S205 - S208
Prothrombotic risk factors in childhood stroke and venous thrombosis C. HellerS. BeckerW. Kreuz THROMBOPHILIA Pages: S117 - S121
Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis – Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation R. SchobessR. JunkerU. Nowak-Göttl THROMBOPHILIA Pages: S105 - S108
Coagulation-associated complications of indwelling arterial and central venous catheters during heparin prophylaxis – a prospective study R. HentschelU. WiescholekG. Jorch THROMBOPHILIA Pages: S126 - S129
Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters C. WermesM. Depka ProndzinskiK.-W. Sykora THROMBOPHILIA Pages: S143 - S146
The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases N. NoheA. FlemmerK. Auberger THROMBOPHILIA Pages: S134 - S139
The course of fibrinolytic proteins in children with malignant bone tumours U. Nowak-GöttlN. MünchowS. Ehrenforth THROMBOPHILIA Pages: S151 - S153
Severe protein C deficiency and aseptic osteonecrosis of the hip joint: a case report C. WermesF. BergmannK.-W. Sykora THROMBOPHILIA Pages: S159 - S161
When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study H. PollmannH. RichterH. Jürgens HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S166 - S170
Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding – Successful thrombolysis under heparin therapy C. Escuriola EttingshausenI. Martinez SaguerW. Kreuz HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S180 - S182
DDAVP treatment in a child with von Willebrand disease type 2M C. Mauz-KörholzU. BuddeU. Göbel HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S174 - S176
Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency – A feasibility pilot study W. D. KreuzW. SchneiderU. Nowak-Göttl CONSUMPTION COAGULOPATHY AND DIC Pages: S187 - S191
Post-trauma coagulation and fibrinolysis in children suffering from severe cerebro-cranial trauma S. BeckerW. SchneiderU. Nowak-Göttl CONSUMPTION COAGULOPATHY AND DIC Pages: S197 - S202
Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles-mumps-rubella-vaccine) and after therapy with Co-Trimoxazole A. MüllerF. KertzscherH. Lenk LABORATORY INVESTIGATIONS Pages: S209 - S210
The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis H. G. KochP. NabelU. Nowak-Göttl THROMBOPHILIA Pages: S113 - S116
Role of genetic prothrombotic risk factors in childhood caval vein thrombosis N. MünchowA. KoschU. Nowak-Göttl THROMBOPHILIA Pages: S109 - S112
Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood S. EhrenforthR. Junkerfor the Childhood Thrombophilia Study Group THROMBOPHILIA Pages: S97 - S104